Literature DB >> 25383786

Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion.

Hilary S Jericho1, Elizabeth Kaurs, Renze Boverhof, Alex Knisely, Benjamin L Shneider, Henkjan J Verkade, Peter F Whitington.   

Abstract

OBJECTIVES: Partial external bile diversion (PEBD) is an established therapy for low-γ-glutamyl transferase (GGT) progressive familial intrahepatic cholestasis (PFIC). This study sought to determine whether the dynamics of the cholic acid (CA) and chenodeoxycholic acid (CDCA) pools in subjects with low-GGT-PFIC with successful PEBD were equivalent to those achieved with successful liver transplantation (LTX).
METHODS: The kinetics of CA and CDCA metabolism were measured by stable isotope dilution in plasma samples in 5 subjects with PEBD, all with intact canalicular bile salt export pump expression and compared with subjects with low-GGT-PFIC with successful LTX. Stomal loss of bile acids was measured in subjects with PEBD.
RESULTS: The fractional turnover rate for CA in the PEBD group ranged from 0.5 to 4.2/day (LTX group, range 0.2-0.9/day, P = 0.076) and for CDCA from 0.7 to 4.5/day (LTX group 0.3-0.4/day, P = 0.009). The CA and CDCA pool sizes were equivalent between groups; however, pool composition in PEBD was somewhat more hydrophilic. The CA/CDCA ratio in PEBD ranged from 0.9 to 19.5, whereas in LTX it ranged from 0.5 to 2.6. Synthesis rates computed from isotope dilution correlated well with timed output for both CA (r2 = 0.760, P = 0.024) and CDCA (r2 = 0.690, P = 0.021).
CONCLUSIONS: PEBD results in bile acid fractional turnover rates greater than LTX, pool sizes equivalent to LTX, and pool composition that is at least as hydrophilic as produced by LTX.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25383786      PMCID: PMC4418648          DOI: 10.1097/MPG.0000000000000630

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  29 in total

1.  Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.

Authors:  M Melter; B Rodeck; R Kardorff; P F Hoyer; C Petersen; A Ballauff; J Brodehl
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans.

Authors:  C V Hulzebos; L Renfurm; R H Bandsma; H J Verkade; T Boer; R Boverhof; H Tanaka; I Mierau; P J Sauer; F Kuipers; F Stellaard
Journal:  J Lipid Res       Date:  2001-11       Impact factor: 5.922

Review 3.  Progressive familial intrahepatic cholestasis. Genetic basis and treatment.

Authors:  E Jacquemin
Journal:  Clin Liver Dis       Date:  2000-11       Impact factor: 6.126

4.  Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

Authors:  P L Jansen; S S Strautnieks; E Jacquemin; M Hadchouel; E M Sokal; G J Hooiveld; J H Koning; A De Jager-Krikken; F Kuipers; F Stellaard; C M Bijleveld; A Gouw; H Van Goor; R J Thompson; M Müller
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

5.  The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.

Authors:  Jane-L Lew; Annie Zhao; Jinghua Yu; Li Huang; Nuria De Pedro; Fernando Peláez; Samuel D Wright; Jisong Cui
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

6.  Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.

Authors:  Amethyst C Kurbegov; Kenneth D R Setchell; Joel E Haas; Gary W Mierau; Michael Narkewicz; John D Bancroft; Frederick Karrer; Ronald J Sokol
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

7.  A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion.

Authors:  Ludmila Pawlikowska; Annemiek Groen; Elaine F Eppens; Cindy Kunne; Roelof Ottenhoff; Norbert Looije; A S Knisely; Nigel P Killeen; Laura N Bull; Ronald P J Oude Elferink; Nelson B Freimer
Journal:  Hum Mol Genet       Date:  2004-02-19       Impact factor: 6.150

8.  Characterization of mutations in ATP8B1 associated with hereditary cholestasis.

Authors:  Leo W J Klomp; Julie C Vargas; Saskia W C van Mil; Ludmila Pawlikowska; Sandra S Strautnieks; Michiel J T van Eijk; Jenneke A Juijn; Carlos Pabón-Peña; Lauren B Smith; Joseph A DeYoung; Jane A Byrne; Justijn Gombert; Gerda van der Brugge; Ruud Berger; Irena Jankowska; Joanna Pawlowska; Erica Villa; A S Knisely; Richard J Thompson; Nelson B Freimer; Roderick H J Houwen; Laura N Bull
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass.

Authors:  P J Kaliciński; H Ismail; I Jankowska; A Kamiński; J Pawłowska; T Drewniak; M Markiewicz; M Szymczak
Journal:  Eur J Pediatr Surg       Date:  2003-10       Impact factor: 2.191

10.  Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.

Authors:  Frank Chen; M Ananthanarayanan; Sukru Emre; Ezequiel Neimark; Laura N Bull; A S Knisely; Sandra S Strautnieks; Richard J Thompson; Margret S Magid; Ronald Gordon; N Balasubramanian; Frederick J Suchy; Benjamin L Shneider
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  5 in total

1.  Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.

Authors:  Kasper S Wang; Greg Tiao; Lee M Bass; Paula M Hertel; Douglas Mogul; Nanda Kerkar; Matthew Clifton; Colleen Azen; Laura Bull; Philip Rosenthal; Dylan Stewart; Riccardo Superina; Ronen Arnon; Molly Bozic; Mary L Brandt; Patrick A Dillon; Annie Fecteau; Kishore Iyer; Binita Kamath; Saul Karpen; Frederick Karrer; Kathleen M Loomes; Cara Mack; Peter Mattei; Alexander Miethke; Kyle Soltys; Yumirle P Turmelle; Karen West; Jessica Zagory; Cat Goodhue; Benjamin L Shneider
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

2.  A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.

Authors:  Sarah A Taylor; Xin-Yi Yeap; Jiao-Jing Wang; Kyle D Gromer; Alyssa Kriegermeier; Richard M Green; Zheng J Zhang
Journal:  Physiol Rep       Date:  2020-05

3.  Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients.

Authors:  Teng Liu; Ren-Xue Wang; Jun Han; Yi-Ling Qiu; Christoph H Borchers; Victor Ling; Jian-She Wang
Journal:  Ann Transl Med       Date:  2020-03

4.  Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.

Authors:  Laura N Bull; Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Jennifer L Dodge; Karan Emerick; Catherine Wanty; Sami Wali; Samra Blanchard; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Roderick Houwen; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Etienne Sokal; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson
Journal:  Hepatol Commun       Date:  2018-03-30

Review 5.  Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.

Authors:  Huey-Ling Chen; Shang-Hsin Wu; Shu-Hao Hsu; Bang-Yu Liou; Hui-Ling Chen; Mei-Hwei Chang
Journal:  J Biomed Sci       Date:  2018-10-26       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.